Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Metabolic Disorders Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Metabolic Disorders Drugs market segmented into
Tablet
Injection
Based on the end-use, the global Metabolic Disorders Drugs market classified into
Diabetes
Disorders of the Thyroid and Pituitary Gland
Others
Based on geography, the global Metabolic Disorders Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Zealand Pharma
Rhythm
OxThera
Biophytis
Biophytis
Zafgen
PerkinElmer
Eternygen
Pronutria Biosciences
MedGenome
CellCentric
Nimbus Therapeutics
Mitobridge
Exelixis, Inc.
Outpost Medicine
Anchor Therapeutics
Verva Pharmaceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL METABOLIC DISORDERS DRUGS INDUSTRY
2.1 Summary about Metabolic Disorders Drugs Industry
2.2 Metabolic Disorders Drugs Market Trends
2.2.1 Metabolic Disorders Drugs Production & Consumption Trends
2.2.2 Metabolic Disorders Drugs Demand Structure Trends
2.3 Metabolic Disorders Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tablet
4.2.2 Injection
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Diabetes
4.3.2 Disorders of the Thyroid and Pituitary Gland
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tablet
5.2.2 Injection
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Diabetes
5.3.2 Disorders of the Thyroid and Pituitary Gland
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tablet
6.2.2 Injection
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Diabetes
6.3.2 Disorders of the Thyroid and Pituitary Gland
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tablet
7.2.2 Injection
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Diabetes
7.3.2 Disorders of the Thyroid and Pituitary Gland
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tablet
8.2.2 Injection
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Diabetes
8.3.2 Disorders of the Thyroid and Pituitary Gland
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tablet
9.2.2 Injection
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Diabetes
9.3.2 Disorders of the Thyroid and Pituitary Gland
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Zealand Pharma
10.1.2 Rhythm
10.1.3 OxThera
10.1.4 Biophytis
10.1.5 Biophytis
10.1.6 Zafgen
10.1.7 PerkinElmer
10.1.8 Eternygen
10.1.9 Pronutria Biosciences
10.1.10 MedGenome
10.1.11 CellCentric
10.1.12 Nimbus Therapeutics
10.1.13 Mitobridge
10.1.14 Exelixis, Inc.
10.1.15 Outpost Medicine
10.1.16 Anchor Therapeutics
10.1.17 Verva Pharmaceuticals
10.2 Metabolic Disorders Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Zealand Pharma
10.2.2 Rhythm
10.2.3 OxThera
10.2.4 Biophytis
10.2.5 Biophytis
10.2.6 Zafgen
10.2.7 PerkinElmer
10.2.8 Eternygen
10.2.9 Pronutria Biosciences
10.2.10 MedGenome
10.2.11 CellCentric
10.2.12 Nimbus Therapeutics
10.2.13 Mitobridge
10.2.14 Exelixis, Inc.
10.2.15 Outpost Medicine
10.2.16 Anchor Therapeutics
10.2.17 Verva Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Metabolic Disorders Drugs Product Type Overview
2.Table Metabolic Disorders Drugs Product Type Market Share List
3.Table Metabolic Disorders Drugs Product Type of Major Players
4.Table Brief Introduction of Zealand Pharma
5.Table Brief Introduction of Rhythm
6.Table Brief Introduction of OxThera
7.Table Brief Introduction of Biophytis
8.Table Brief Introduction of Biophytis
9.Table Brief Introduction of Zafgen
10.Table Brief Introduction of PerkinElmer
11.Table Brief Introduction of Eternygen
12.Table Brief Introduction of Pronutria Biosciences
13.Table Brief Introduction of MedGenome
14.Table Brief Introduction of CellCentric
15.Table Brief Introduction of Nimbus Therapeutics
16.Table Brief Introduction of Mitobridge
17.Table Brief Introduction of Exelixis, Inc.
18.Table Brief Introduction of Outpost Medicine
19.Table Brief Introduction of Anchor Therapeutics
20.Table Brief Introduction of Verva Pharmaceuticals
21.Table Products & Services of Zealand Pharma
22.Table Products & Services of Rhythm
23.Table Products & Services of OxThera
24.Table Products & Services of Biophytis
25.Table Products & Services of Biophytis
26.Table Products & Services of Zafgen
27.Table Products & Services of PerkinElmer
28.Table Products & Services of Eternygen
29.Table Products & Services of Pronutria Biosciences
30.Table Products & Services of MedGenome
31.Table Products & Services of CellCentric
32.Table Products & Services of Nimbus Therapeutics
33.Table Products & Services of Mitobridge
34.Table Products & Services of Exelixis, Inc.
35.Table Products & Services of Outpost Medicine
36.Table Products & Services of Anchor Therapeutics
37.Table Products & Services of Verva Pharmaceuticals
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global Metabolic Disorders Drugs Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global Metabolic Disorders Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global Metabolic Disorders Drugs Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global Metabolic Disorders Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Metabolic Disorders Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Metabolic Disorders Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Metabolic Disorders Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Metabolic Disorders Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Metabolic Disorders Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Metabolic Disorders Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Metabolic Disorders Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Disorders of the Thyroid and Pituitary Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Disorders of the Thyroid and Pituitary Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Disorders of the Thyroid and Pituitary Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Disorders of the Thyroid and Pituitary Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Disorders of the Thyroid and Pituitary Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Disorders of the Thyroid and Pituitary Gland Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Zealand Pharma 2017-2020e
66.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Rhythm 2017-2020e
67.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of OxThera 2017-2020e
68.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Biophytis 2017-2020e
69.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Biophytis 2017-2020e
70.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Zafgen 2017-2020e
71.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of PerkinElmer 2017-2020e
72.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Eternygen 2017-2020e
73.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Pronutria Biosciences 2017-2020e
74.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of MedGenome 2017-2020e
75.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of CellCentric 2017-2020e
76.Figure Metabolic Disorders Drugs Sales Revenue (Million USD) of Nimbus Therapeutics 2017-2020e
77.Figure Metabolic Disorders Drugs S